Synergistic complement lysis by monoclonal antibodies to the human leukocyte common antigen requires both the classical and alternative pathways
- 1 June 1987
- journal article
- research article
- Published by Elsevier in Molecular Immunology
- Vol. 24 (6), 587-594
- https://doi.org/10.1016/0161-5890(87)90039-3
Abstract
No abstract availableThis publication has 14 references indexed in Scilit:
- THERAPEUTIC POTENTIAL OF MONOCLONAL ANTIBODIES TO THE LEUKOCYTE-COMMON ANTIGENTransplantation, 1985
- A FUNCTION FOR HUMAN T200 IN NATURAL KILLER CYTOLYSISTransplantation, 1983
- Immunobiology of Tissue Transplantation: A Return to the Passenger Leukocyte ConceptAnnual Review of Immunology, 1983
- The mechanism of synergistic complement‐mediated lysis of rat red cells by monoclonal IgG antibodiesEuropean Journal of Immunology, 1983
- Monoclonal antibody to a human leukocyte‐specific membrane glycoprotein probably homologous to the leukocyte‐common (L‐C) antigen of the ratEuropean Journal of Immunology, 1980
- Differences in the ability of rat IgG subclasses to consume complement in homologous and heterologous serumImmunology Letters, 1980
- Rat × rat hybrid myelomas and a monoclonal anti-Fd portion of mouse IgGNature, 1979
- Modulation of the alternative complement pathways by beta 1 H globulin.The Journal of Experimental Medicine, 1976
- Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Nature, 1970
- THE ATTRACTIONS OF PROTEINS FOR SMALL MOLECULES AND IONSAnnals of the New York Academy of Sciences, 1949